Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04230889 · ClinicalTrials.gov registry record · NA
Evaluation of Glucose Control in Patients With Diabetes
A NA study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT04230889: Completed NA study, sponsored by Abbott Nutrition.
NCT04230889 is a NA study that has completed, run by Abbott Nutrition. The registered enrollment target is 125 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04230889, a NA study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
A randomized, multicenter, open-labeled, parallel, three group pilot study to evaluate the impact of a diabetes-specific nutritional shake on glucose control.
Primary Outcome
Change versus baseline phase
Interventions
- OTHER Usual Diet Group
- OTHER Group 1 Nutritional Shake
- OTHER Group 2 Nutritional Shake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2017-02-06 |
| Est. Completion | 2018-02-15 |
| Phase | NA |
What the finished NCT04230889 record still lists
NCT04230889 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 3 interventions - of which Usual Diet Group is the first listed.
NCT04230889 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04230889 about?
NCT04230889 is a clinical study titled "Evaluation of Glucose Control in Patients With Diabetes". A randomized, multicenter, open-labeled, parallel, three group pilot study to evaluate the impact of a diabetes-specific nutritional shake on glucose control.
What is the current status of trial NCT04230889?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2017-02-06. Estimated completion is 2018-02-15.
What interventions are being tested in trial NCT04230889?
The interventions under investigation include: Usual Diet Group (OTHER), Group 1 Nutritional Shake (OTHER), Group 2 Nutritional Shake (OTHER).
Who is sponsoring clinical trial NCT04230889?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04230889's enrollment target sits among peer trials
125 753rd of 2000 higher than 1,243 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI